Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (81-90 of 365) with videos related to

Pageof 37
Sort By:
The Journal of Endocrinology|January 1, 1975
Inhibition of oestradiol binding to mouse uterine and vaginal oestrogen receptors by triphenylethylenesV C Jordan, S Koerner
European Journal of Cancer|March 1, 1975
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorV C Jordan, S Koerner
Cancer Surveys|January 1, 1993
Risk factors and the prevention of breast cancer with tamoxifenM Morrow, V C Jordan
The Journal of Endocrinology|February 1, 1978
Effect of non-steroidal anti-oestrogens on the concentration of rat uterine progesterone receptorsV C Jordan, G Prestwich
Endocrinology|April 1, 1989
Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estroneV C Jordan, R Koch
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Meeting report: long-term antihormonal therapy for breast cancerA Costa, V C Jordan
Molecular and Cellular Endocrinology|August 1, 1982
Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusV C Jordan, B Gosden
The Journal of Endocrinology|February 1, 1976
Tamoxifen as an anti-tumour agent: role of oestradiol and prolactinV C Jordan, S Koerner
Endocrine Reviews|June 16, 1999
Tamoxifen, raloxifene, and the prevention of breast cancerV C Jordan, M Morrow
BMJ (Clinical Research Ed.)|August 6, 1999
Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancerV C Jordan, M Morrow
Pageof 37

Showing results (81-90 of 365) with videos related to

Sort By:
Pageof 37
The Journal of Endocrinology|January 1, 1975
Inhibition of oestradiol binding to mouse uterine and vaginal oestrogen receptors by triphenylethylenesV C Jordan, S Koerner
European Journal of Cancer|March 1, 1975
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorV C Jordan, S Koerner
Cancer Surveys|January 1, 1993
Risk factors and the prevention of breast cancer with tamoxifenM Morrow, V C Jordan
The Journal of Endocrinology|February 1, 1978
Effect of non-steroidal anti-oestrogens on the concentration of rat uterine progesterone receptorsV C Jordan, G Prestwich
Endocrinology|April 1, 1989
Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estroneV C Jordan, R Koch
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Meeting report: long-term antihormonal therapy for breast cancerA Costa, V C Jordan
Molecular and Cellular Endocrinology|August 1, 1982
Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusV C Jordan, B Gosden
The Journal of Endocrinology|February 1, 1976
Tamoxifen as an anti-tumour agent: role of oestradiol and prolactinV C Jordan, S Koerner
Endocrine Reviews|June 16, 1999
Tamoxifen, raloxifene, and the prevention of breast cancerV C Jordan, M Morrow
BMJ (Clinical Research Ed.)|August 6, 1999
Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancerV C Jordan, M Morrow
Pageof 37